nab-Paclitaxel and cisplatin followed by cisplatin and radiation (Arm 1) and nab-paclitaxel followed by cetuximab and radiation (Arm 2) for locally advanced head and neck squamous-cell carcinoma: a multicenter, non-randomized phase 2 trial - Peter Oppelt, Jessica Ley, Mackenzie Daly, Jason Rich, Randal Paniello, Ryan S. Jackson, Patrik Pipkorn, Jingxia Liu, Hiram Gay, Kevin Palka, Prakash Neupane, Steven Powell, William C. Spanos, Mark Gitau, Jose Zevallos - Dissemin

Dissemin is shutting down on January 1st, 2025

Language
Login

Published in

Springer (part of Springer Nature), Medical Oncology, 4(38), 2021

DOI: 10.1007/s12032-021-01479-w

Links

Springer (part of Springer Nature)

Tools

Export citation

Search in Google Scholar

nab-Paclitaxel and cisplatin followed by cisplatin and radiation (Arm 1) and nab-paclitaxel followed by cetuximab and radiation (Arm 2) for locally advanced head and neck squamous-cell carcinoma: a multicenter, non-randomized phase 2 trial

Journal article published in 2021 by Peter Oppelt, Jessica Ley, Mackenzie Daly, Jason Rich, Randal Paniello, Ryan S. Jackson, Patrik Pipkorn, Jingxia Liu, Hiram Gay, Kevin Palka, Prakash Neupane, Steven Powell, William C. Spanos, Mark Gitau, Jose Zevallos and other authors.

This paper was not found in any repository, but could be made available legally by the author.

This paper was not found in any repository, but could be made available legally by the author.

Full text: Unavailable

Green circle

Preprint: archiving allowed

Upload

Green circle

Postprint: archiving allowed

Upload

Red circle

Published version: archiving forbidden

Policy details

Data provided by

SHERPA/RoMEO